English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduLabeling cancer cells with genetic barcodes
“In ReSisTrace, we label cancer cells uniquely with genetic barcodes and allow them to divide once, so that we get two identical sister cells that share the same barcode.
Tag: Cancer
New tumor spatial mapping tool will help clinicians assess aggressiveness of cancer and personalize treatment
Scientists have developed a new AI tool that maps the function of proteins in a cancerous tumour, enabling clinicians to decide how to target treatment in a more precise way.
Clues to cancer drug’s deadly side effects could make it safer
For some leukemia patients, their only treatment option carries a risk of heart failure
New Research Shows Patients with Cancer who Suffered a Major Adverse Financial Event More Likely to be Diagnosed With Advanced Stage Disease
New findings led by researchers at the American Cancer Society and the National Cancer Institute show more than one-third of cancer patients had a major adverse financial event – bankruptcy, lien, or eviction – before their cancer diagnosis.
$1.1M Grant Supports Research in Breast Cancer Survivorship among Black Women
Bo (Bonnie) Qin, PhD, researcher and cancer epidemiologist in the Section of Cancer Epidemiology and Health Outcomes at Rutgers Cancer Institute of New Jersey, has received $1.1M from the American Cancer Society to support her research on the impact of lifestyle patterns, social determinants of health, and inflammatory mechanisms on breast cancer survivorship among Black women.
Artificially intelligent software provides a detailed look at jets of plasma used to treat cancer
Artificially intelligent software has been developed to enhance medical treatments that use jets of electrified gas known as plasma. Developed by researchers at Princeton Plasma Physics Laboratory and the George Washington University, the computer code predicts the chemicals emitted by cold atmospheric plasma devices, which can be used to treat cancer and sterilize surfaces.
UChicago Medicine among the first to offer histotripsy for liver tumors
UChicago Medicine was the first hospital in Illinois to treat patients using histotripsy, a new noninvasive technology that uses ultrasound energy to precisely destroy liver tumors.
Director of Oncology Services Northern Region Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
George Raptis, MD, MBA, begins role at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health as director of Oncology Services for the Northern Region of New Jersey.
Memorial Sloan Kettering Cancer Center Launches Bilingual Campaign Promoting Screenings in the Hispanic Community
Today, Memorial Sloan Kettering Cancer Center (MSK), in collaboration with Miami-based creative agency Alma, launched a bilingual public service campaign to promote the importance of routine cancer screenings.
New Prostate Cancer Report Card keeps treatment options simple to understand
A new prostate cancer resource – the Prostate Cancer Outcomes Report Card – hopes to make it easier for men and their families to better understand the treatment options and outcomes.
New Potential Immunotherapies for Pancreatic Cancer
Pancreatic cancer can be a devastating diagnosis due to its extremely aggressive nature and low survival rate.
New Cancer Research Plan Aims to Improve Quality of Life for Cancer Survivors
CIHR’s Institute of Cancer Research (ICR) is launching a new five-year plan with cancer survivorship as a priority research topic. With the rate of cancer survivorship predicted to increase steadily over the next decades, survivor research will promote the Canadian…
La salud de las mamas durante la menopausia
Su riesgo de tener cáncer de mama aumenta con la edad, especialmente después de la menopausia. Alrededor de 8 de cada 10 casos de cáncer de mama ocurren en mujeres de más de 50 años.
Expert Analysis: Black Americans Have Highest Cancer Mortality Rates In The United States
For Black History Month, Hackensack Meridian Health offers experts on some of the reasons behind higher cancer rates in the Black community and how to reverse the trends.
Mapeamento dos comportamentos celulares em glioma de alto grau para a melhora do tratamento
Gliomas de alto grau são tumores cancerígenos que se espalham rapidamente no cérebro ou na medula espinhal.
Mapeo de los comportamientos celulares en glioma de alto grado para la mejora del tratamiento
Los gliomas de alto grado son tumores cancerígenos que se propagan rápidamente en el cerebro o en la médula espinal.
Brain Protein’s Virus-Like Structure May Help Explain Cancer-Induced Memory Loss
In a rare but serious complication of cancer, the immune system can start attacking the brain, causing rapid memory loss. What triggers this was largely unknown. Now, researchers at University of Utah Health have found that some tumors can release a virus-like protein, kickstarting an out-of-control autoimmune reaction.
Show Your Heart Love for American Heart Month — Johns Hopkins Medicine Adult and Pediatric Experts Available to Discuss Heart Health
February is American Heart Month, a time for awareness of heart-related conditions that affect adults and children. Johns Hopkins Medicine experts are available all month to discuss various aspects of heart health.
Weight loss intervention in people with type 2 diabetes influences cancer-associated proteins
A weight loss intervention in people with type 2 diabetes was found to alter levels of cancer-related proteins, according to the findings of a new University of Bristol-led study.
New technology makes cancer easier for immune system to find and destroy
A new technology to increase visibility of cancer cells to the immune system using CRISPR has been developed, and could lead to a new way to treat cancer.
Fighting Viruses that Cause Cancer
In research labs and clinical settings, faculty across Tufts School of Medicine and Graduate School of Biomedical Sciences are investigating cancer caused by herpes, HIV, HPV, and other viruses
Researchers Discover Why One Type of Chemotherapy Works Best in Bladder Cancer
Tisch Cancer Institute researchers discovered that a certain type of chemotherapy improves the immune system’s ability to fight off bladder cancer, particularly when combined with immunotherapy, according to a study published in Cell Reports Medicine in January.
Hackensack Meridian Health Selected as Inaugural Member of ARPA-H Investor Catalyst Hub Spoke Network
HMH joins nationwide network working to accelerate transformative health solutions
Computer Models Fill Critical Knowledge Gaps to Help Reduce Cancer Disparities
Reducing health disparities in incidence and mortality for major types of cancers can be aided by sophisticated computer modeling efforts, according to new, wide-ranging perspectives from researchers at Georgetown University’s Lombardi Comprehensive Cancer Center and colleagues around the country.
AACI Congratulates Dr. Monica Bertagnolli on Confirmation as NIH Director
The Association of American Cancer Institutes (AACI) congratulates Monica Bertagnolli, MD, on her U.S. Senate confirmation today as the next director of the National Institutes of Health (NIH).
Improving the efficacy of cancer immunotherapy with modified CAR-T cells
CAR-T cell therapy is a last hope for many patients with blood, bone marrow or lymph gland cancer when other treatments such as chemotherapy are unsuccessful. A limiting factor of this otherwise very effective and safe therapy is that the cells used in the process quickly reach a state of exhaustion.
The challenges of cancer caregiving
As more cancer care is delivered in outpatient treatment centers such as Fred Hutchinson Cancer Center in Seattle, the burden on cancer caregivers is evolving. Fred Hutch has developed a package of stories to support and celebrate the role of caregivers in cancer care.
High biological age may increase the risk of dementia and stroke
People who have a higher biological age than their actual chronological age have an increased risk of stroke and dementia. The findings suggest that by slowing down the body’s aging processes, it may be possible to reduce or delay the onset of disease.
Mount Sinai Researchers Receive $7 Million to Improve Outcomes for High-risk Blood Cancer Patients From the Multiple Myeloma Research Foundation
The Mount Sinai Health System has received a $7 million grant from the Multiple Myeloma Research Foundation for a three-year project that aims to fast-track novel translational concepts to improve outcomes for people with high risk myeloma, the second most common blood cancer in the United States.
Case Western Reserve University School of Medicine launches Institute for Glial Sciences
Case Western Reserve University has established an Institute for Glial Sciences to advance research of glial cells and their critical role in the health and diseases of the nervous systems, including multiple sclerosis, Alzheimer’s, pediatric leukodystrophies, Autism spectrum disorders, Parkinson’s disease and cancer.
New NUS study provides insights into early breast cancer development in individuals with BRCA2 mutations
A pioneering study led by the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore and the University of Cambridge (UK) has uncovered vital insights into the distinct effects of BRCA2 mutations on breast tissue cells, shedding light on early breast cancer development in people with BRCA2 mutations.
Markey Cancer Center study provides valuable insights into drivers of cancer risk
As people age, the DNA in their cells begins to accumulate genetic mutations. Mosaic chromosomal alterations (mCAs), a category of mutations acquired in blood cells, are linked with a 10-fold increased risk of developing blood cancer. mCAs hold promise as a tool to identify people at high risk of developing certain cancers and diseases, but they have not yet been studied among a large, diverse cohort of people – a critical step required before such testing can be developed. University of Kentucky Markey Cancer Center researcher Yasminka A. Jakubek, Ph.D., has led the first large-scale effort to understand the co-occurrence of mCAs among individuals of diverse ancestries. The study was published in Nature Genetics Oct. 30.
American Cancer Society Updates Lung Cancer Screening Guideline: Nearly Five Million U.S. Adults who Smoke and Formerly Smoked Now Recommended for Testing
The American Cancer Society releasesan update of its lung cancer screening guideline to help reduce the number of people dying from the disease due to smoking history.
Cancer drug shows promise targeting genetic weakness in some tumors, comments Virginia Tech expert
In an invited commentary, Kathleen Mulvaney, assistant professor with the Fralin Biomedical Research Institute at VTC, talks about the potential of a new drug that has shown early promise in clinical trials for solid tumors by killing cancer cells that lack specific tumor suppressor genes.
High insulin levels directly linked to pancreatic cancer
First detailed explanation of why people with obesity and Type 2 diabetes are at an increased risk of pancreatic cancer
New Study Shows Insurance Coverage Disruptions Affect Key Cancer Screenings for U.S. Adults
A new study by researchers at the American Cancer Society shows that adults in the United States with prior insurance coverage disruptions are significantly less likely to receive guideline-concordant and past-year cancer screening, compared to people with continuous coverage.
New Study Shows Adults Treated for Non-Small Cell Lung Cancer Vulnerable to Hazards of Wildfires
New research by scientists at the American Cancer Society and the University of California, San Francisco, shows individuals in the United States undergoing radiotherapy for non-small cell lung cancer who are exposed to wildfires near the treating facility have worse overall survival than unexposed individuals.
New Study Finds Limited Documentation of Cost Discussions With Patients Newly Diagnosed With Advanced Cancer
A new study by researchers at the American Cancer Society and the National Cancer Institute, shows only about a quarter of individuals newly diagnosed with advanced cancers had documented physician discussions about costs of care, which may hinder identifying patient needs and tracking outcomes of referrals for assistance.
New Research Shows Patients Receiving Cancer Treatment Understand Health Insurance Basics; Important Knowledge Gaps Remain
A new study by researchers at the American Cancer Society showed among patients receiving outpatient cancer treatment in two sites, most people could understand basic health insurance terms, such as premiums and deductibles.
Scientists have discovered how extracellular structures affect the metastases of cancerous tumors
The dependence between biomechanical properties of extracellular matrix and the development of tumor cells inside it was proven by scientists. This will allow to create more realistic models for studying growth of cancer tumors and metastases.
Common chemotherapy drugs don’t work like doctors thought, with big implications for drug discovery
A new study from the University of Wisconsin–Madison suggests that chemotherapy may not be reaching its full potential, in part because researchers and doctors have long misunderstood how some of the most common cancer drugs actually ward off tumors.
Anti-anxiety drug may improve brain cancer survival chances
A new research study shows that cerebrospinal fluid reduces current treatment efficacy in brain cancer and identifies new therapeutic opportunities.
Novel small molecule 5D4 disrupts several molecular pathways, including MYC, that lead to cancer growth
Researchers at Baylor College of Medicine have identified a small molecule named 5D4 that can suppress the growth of breast and ovarian cancers in animal models.
Preventing collateral damage in cancer treatment
Using a simple concept and a patented Sandia sensor that detects radioactive materials, a team at Sandia National Laboratories has developed a patch to stop damage to healthy tissue during proton radiotherapy, one of the best tools to target certain cancerous tumors.
Researchers identify ‘switch’ to activate cancer cell death
A research team from the UC Davis Comprehensive Cancer Center has identified a crucial epitope (a protein section that can activate the larger protein) on the CD95 receptor that can cause cells to die.
Highest risk patients with clear-cell renal cell carcinoma benefit from adjuvant everolimus
New study finds everolimus benefits high-risk kidney cancer patients
Does diabetes affect the survival of individuals with colorectal cancer?
Study reveals a link between complicated diabetes and a higher risk of death
MEDSIR presents the results of three new studies at ESMO 2023: LUPER, focusing on lung cancer, and two translational studies of PHERGain in breast cancer
MEDSIR, a company specializing in the strategic design of independent clinical research, today presented the results of three new studies at the European Society for Medical Oncology (ESMO 2023).
Adding Immunotherapy to Chemotherapy Regimen Improves Survival in Metastatic Bladder Cancer Patients
A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients with an advanced type of bladder cancer. The results were simultaneously reported in The New England Journal of Medicine and at the annual meeting of the European Society for Medical Oncology.
Dual-action drug produces positive results in patients with advanced neuroendocrine tumors, trial finds
Cabozantinib, which targets tumor cell growth and tumor blood vessel growth, sharply improved progression-free survival over placebo in patients with extra-pancreatic and pancreatic neuroendocrine tumors